TCF/LEF Luciferase Reporter Lentivirus (Wnt/β-catenin Signaling Pathway)

Catalog #
79787
$875 *
Size: 500 µl x 2
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

TCF/LEF Luciferase Reporter Lentivirus (Wnt/β-catenin Signaling Pathway) are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase reporter under the control of TCF (T cell factor)/LEF (lymphoid enhancer factor)-responsive element located upstream of the minimal TATA promoter.  The lentiviruses also transduce a puromycin selection gene (Figure 1). After transduction, activation of the Wnt/β-catenin signaling pathway in target cells can be monitored by assessing luciferase expression.

Figure 1. Schematic of the lenti-vector used to generate the TCF/LEF Luciferase Reporter Lentivirus (Wnt/β-catenin Signaling Pathway).

This product has been cited 5 times.

Synonyms
TCF reporter. LEF reporter, lentivirus reporter, Wnt reporter, β-catenin pathway
Product Info
Storage and Usage
Citations5
Supplied As
Two vials (500 µl x 2) of TCF/LEF Luciferase Reporter Lentivirus (Wnt/β-catenin Signaling Pathway) at ≥107 TU/ml. The titer will vary with each lot; the exact value is provided with each shipment.
Materials Required But Not Supplied
Name Ordering Information
HEK293 cells  
Thaw Medium 9 BPS Bioscience #79665
Lenti-Fuse™ Polybrene Viral Transduction Enhancer BPS Bioscience #78939
LiCl Sigma #L7026
Recombinant Mouse Wnt-3a Protein R&D Systems #1324-WN
ONE-Step™ Luciferase Assay System BPS Bioscience #60690
96-well white clear-bottom assay plate Corning #3610
Luminometer  
Formulation

The lentiviruses were produced from HEK293T cells. Supplied in medium containing 90% DMEM + 10% FBS. Virus particles can be packaged in custom formulations and produced at higher titers by special request, for an additional fee.  

Background

The Wnt signaling pathway is a well described regulator of organism development and cell fate specification. Cellular pluripotency and differentiation of multiple lineages, including cardiomyocytes and neurons are modulated by this pathway. There are 19 Wnt ligands and 10 Frizzled receptors, which stimulate canonical as well as non-canonical Wnt pathways. In the canonical pathway, cell activation by a Wnt ligand leads to the stabilization and nuclear translocation of β-catenin and subsequent activation of TCF (T cell factor)/LEF (lymphoid enhancer factor) transcription factor. Dysfunction of these pathways can result in cancer and also type 2 diabetes. A deeper understanding of the role of this pathway and the development of new therapeutic strategies around it will open new clinical avenues.

References

Tian S., et al., Blood. 1994; 84(6):1760-1764.
Zhong, Z., et al., Science. 1994; 264(5155):95-98.